drugset / Trial / NCT00005066

O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma

NCT00005066

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining O6-benzylguanine and carmustine in treating patients who have recurrent, metastatic, or locally advanced soft tissue sarcoma.

Timeline

Start
2000-06
Primary completion
2001-09
Completion
2002-10

Drugs

EvaluationDrugModalityDoseRoute
Subject O6-benzylguanine Small molecule Intravenous
Subject carmustine Small molecule Intravenous

Indications